Mandate

Vinge has acted for Bergs Timber in connection with its acquisition of Fågelfors Hyvleri and refinancing

Vinge has acted for Bergs Timber in connection with its acquisition of all shares in AB Fågelfors Hyvleri, a company with wood pellet production located in Fågelfors, Sweden. 

The purchase price amounts to SEK 48 million, of which SEK 30 million is paid in cash and SEK 18 million is paid in 5,940,594 newly issued class B shares in Bergs Timber. Bergs Timber has also, in connection with the acquisition, made a refinancing of outstanding credit facilities. 

Vinge’s team mainly comprised Jesper Schönbeck, Ulrich Ziche, Sofia Törnroth Nyberg, Astrid Isberg, Stina Bengtsson, Axel Jansson, Pauline Lagerstrand and Viktoria Owetz.

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026